7 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
The natural flavone fukugetin as a mixed-type inhibitor for human tissue kallikreins.
Campus
Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitors.
The Johns Hopkins University
Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development.
University of Naples Federico II
Human kallikrein 6 inhibitors with a para-amidobenzylanmine P1 group identified through virtual screening.
Sanofi Pharmaceuticals
Phage-encoded combinatorial chemical libraries based on bicyclic peptides.
Laboratory of Molecular Biology, Medical Research Council
Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer.
The Johns Hopkins University School of Medicine